Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced a broad body of evidence supporting its Prospera test at the 2026 International Society for Heart ...
Built atop 85 acres of one of Atlanta’s last urban forests, the training center is now wired into what has become the most expansive surveillance network of any city in the U.S., part of more than 60, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results